Sarah Shigdar

Business Services · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Sarah Shigdar

Aptamer Theranostics, led by A/Prof Sarah Shigdar, specializes in the development of aptamers for diagnostic and therapeutic applications, particularly in oncology and neurology. Their projects focus on creating aptamers that enhance tumor diagnosis in pathology labs and serve as drug delivery vehicles, especially for targeting brain disorders like Parkinson's and Alzheimer's diseases. The lab is committed to improving the quality of life for cancer patients through innovative treatments that can cross the blood-brain barrier. They actively seek collaborative partnerships to further advance the use of aptamers as theranostic agents.Explore more
Popular SearchesSarah ShigdarSIC Code 87,873NAICS Code 54,541Show more

Is Sarah Shigdar your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sarah Shigdar

Compare insights from companies similar to Sarah Shigdar, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sarah Shigdar

<$5M
11-50
Private
-
-
N/A
$10.6M
1-10
Private
<$5M
2008
<$5M
11-50
Private
-
2017
TT
Toshihiko TakeuchiChief Scientific Officer
<$5M
11-50
Private
-
2010
N/A
<$5M
11-50
Private
-
1999
BL
Bill LunsfordAssistant Laboratory Director
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2019
N/A
Illustration of an envelope

Sarah Shigdar Tech Stack

A closer look at the technologies used by Sarah Shigdar

Top Business Services Companies

Frequently Asked Questions Regarding Sarah Shigdar

What is Sarah Shigdar's official website?
Sarah Shigdar's official website is www.sarahshigdar.com
What is Sarah Shigdar's Revenue?
Sarah Shigdar's revenue is <$5 Million
What is Sarah Shigdar's SIC code?
Sarah Shigdar's SIC: 87,873
What is Sarah Shigdar's NAICS code?
Sarah Shigdar's NAICS: 54,541
How many employees does Sarah Shigdar have?
Sarah Shigdar has 11-50 employees
What industry does Sarah Shigdar belong to?
Sarah Shigdar is in the industry of: Business Services, Research & Development
What is Sarah Shigdar competition?
Sarah Shigdar top competitors include: rPeptide, Cell Guidance Systems, Abalone Bio, ICB International
What technology does Sarah Shigdar use?
Some of the popular technologies that Sarah Shigdar uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Wix
What does Sarah Shigdar do?

Aptamer Theranostics, led by A/Prof Sarah Shigdar, specializes in the development of aptamers for diagnostic and therapeutic applications, particularly in oncology and neurology. Their projects focus on creating aptamers that enhance tumor diagnosis in pathology labs and serve as drug delivery vehicles, especially for targeting brain disorders like... Parkinson's and Alzheimer's diseases. The lab is committed to improving the quality of life for cancer patients through innovative treatments that can cross the blood-brain barrier. They actively seek collaborative partnerships to further advance the use of aptamers as theranostic agents.Read More

Is Sarah Shigdar a public company?
Sarah Shigdar is private company therefore does not currently have an official ticker symbol
See more information about Sarah Shigdar

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.